BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34721975)

  • 1. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
    Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
    PeerJ; 2021; 9():e12276. PubMed ID: 34721975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A zinc finger protein gene signature enables bladder cancer treatment stratification.
    Zhang J; Zhang C; Cao P; Zheng X; Yu B; Cao H; Gao Z; Zhang F; Wu J; Cao H; Hao C; Sun Z; Wang W
    Aging (Albany NY); 2021 May; 13(9):13023-13038. PubMed ID: 33962398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
    Wu Q; Zheng S; Lin N; Xie X
    BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
    Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
    Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioinformatics analysis of zinc finger protein family reveals potential oncogenic biomarkers in breast cancer.
    An G; Feng L; Hou L; Li X; Bai J; He L; Gu S; Zhao X
    Gene; 2022 Jun; 828():146471. PubMed ID: 35378249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer.
    Xu S; Liu Y; Ma H; Fang S; Wei S; Li X; Lu Z; Zheng Y; Liu T; Zhu X; Xu D; Pan Y
    Front Genet; 2022; 13():834731. PubMed ID: 35432482
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of ZNF family genes in prognosis, immunity, and treatment of esophageal cancer.
    Hong K; Yang Q; Yin H; Wei N; Wang W; Yu B
    BMC Cancer; 2023 Apr; 23(1):301. PubMed ID: 37013470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
    Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y
    Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
    Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
    Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A seven-nuclear receptor-based prognostic signature in breast cancer.
    Wu F; Chen W; Kang X; Jin L; Bai J; Zhang H; Zhang X
    Clin Transl Oncol; 2021 Jul; 23(7):1292-1303. PubMed ID: 33210236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic melatonin-related lncRNA signature in tumor immune microenvironment and drug resistance for breast cancer.
    Gao SC; Wu MD; Zhang XX; Liu YF; Wang CL
    Asian J Surg; 2023 Sep; 46(9):3529-3541. PubMed ID: 37330302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
    Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer.
    Pei J; Li Y; Su T; Zhang Q; He X; Tao D; Wang Y; Yuan M; Li Y
    Front Genet; 2020; 11():912. PubMed ID: 33193571
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
    Sun Y; Yang M; Zhang Q
    Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis.
    Ren H; Shen X; Xie M; Guo X
    Transl Cancer Res; 2024 May; 13(5):2419-2436. PubMed ID: 38881940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic effect and targets of
    Yuan J; Lin M; Yang S; Yin H; Ouyang S; Xie H; Tang H; Ou X; Zeng Z
    Heliyon; 2024 May; 10(10):e31137. PubMed ID: 38778969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis.
    Chen X; Yang C; Wang W; He X; Sun H; Lyu W; Zou K; Fang S; Dai Z; Dong H
    Front Genet; 2023; 14():1025163. PubMed ID: 36911389
    [No Abstract]   [Full Text] [Related]  

  • 19. An autophagy-related long non-coding RNA prognostic model and related immune research for female breast cancer.
    Chen J; Li X; Yan S; Li J; Zhou Y; Wu M; Ding J; Yang J; Yuan Y; Zhu Y; Wu W
    Front Oncol; 2022; 12():929240. PubMed ID: 36591508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic significance of the ZNF gene family in pancreatic cancer: a bioinformatics and experimental study.
    Zhu L; Tu D; Li R; Li L; Zhang W; Jin W; Li T; Zhu H
    Front Genet; 2023; 14():1089023. PubMed ID: 37396042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.